Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC

Condition:   Stage III Esophageal Squamous Cell Carcinoma
Interventions:   Drug: BPF-CCRT (run-in);   Drug: BPF-CCRT (randomized);   Drug: PF-CCRT (randomized)
Sponsor:   National Taiwan University Hospital
Not yet recruiting - verified June 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/2949ioF
via IFTTT